Viela Bio: Viela Bio to Report Fourth Quarter and Full Year 2020 Operating and Financial Results on March 1, 2021

Viela Bio (Nasdaq:VIE), a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for patients suffering from autoimmune and severe inflammatory diseases, today announced it will report its fourth quarter and full year 2020 operating and financial results after the U.S. financial markets close on Monday, March 1, 2021.